0001225208-21-013112.txt : 20211015
0001225208-21-013112.hdr.sgml : 20211015
20211015161610
ACCESSION NUMBER: 0001225208-21-013112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211014
FILED AS OF DATE: 20211015
DATE AS OF CHANGE: 20211015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIMON JAMES
CENTRAL INDEX KEY: 0001195345
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05805
FILM NUMBER: 211326246
MAIL ADDRESS:
STREET 1: 270 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JPMORGAN CHASE & CO
CENTRAL INDEX KEY: 0000019617
STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021]
IRS NUMBER: 132624428
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 383 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2122706000
MAIL ADDRESS:
STREET 1: 383 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: J P MORGAN CHASE & CO
DATE OF NAME CHANGE: 20010102
FORMER COMPANY:
FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/
DATE OF NAME CHANGE: 19960402
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMICAL BANKING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
X0306
4
2021-10-14
0000019617
JPMORGAN CHASE & CO
JPM
0001195345
DIMON JAMES
383 MADISON AVENUE
NEW YORK
NY
10179-0001
1
1
Chairman & CEO
Common Stock
2021-10-14
4
M
0
562430.0000
35.6100
A
912186.0000
D
Common Stock
2021-10-14
4
F
0
375403.0000
162.0350
D
536783.0000
D
Common Stock
8107.9426
I
By 401(k)
Common Stock
2097090.0000
I
By Family Trusts
Common Stock
4828594.0000
I
By GRATs
Common Stock
152940.0000
I
By LLC
Common Stock
871766.0000
I
By Spouse
Stock Appreciation Rights
35.6100
2021-10-14
4
M
0
562430.0000
0.0000
D
2022-01-18
Common Stock
562430.0000
0.0000
D
Reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest.
Exercise of SARs pursuant to 10b5-1 Plan dated August 9, 2021
Stock appreciation rights granted on January 18, 2012, which have a ten-year term, became exercisable in five equal installments beginning January 18, 2013. Shares resulting from exercise must be held at least five years from the grant date.
/s/ David K.F. Gillis under POA
2021-10-15